3,135 reports of this reaction
2.3% of all EPINEPHRINE reports
#7 most reported adverse reaction
NAUSEA is the #7 most commonly reported adverse reaction for EPINEPHRINE, manufactured by Viatris Specialty LLC. There are 3,135 FDA adverse event reports linking EPINEPHRINE to NAUSEA. This represents approximately 2.3% of all 135,553 adverse event reports for this drug.
Patients taking EPINEPHRINE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is a less commonly reported adverse event for EPINEPHRINE, but still significant enough to appear in the safety profile.
In addition to nausea, the following adverse reactions have been reported for EPINEPHRINE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 3,135 FDA reports for EPINEPHRINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 2.3% of all adverse event reports for EPINEPHRINE, making it a notable side effect.
If you experience nausea while taking EPINEPHRINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.